                                 FINAL REPORT
 EXAMINATION:  CHEST (PORTABLE AP)
 
 INDICATION:  ___ M PMHx multiple myeloma (s/p multiple regimens of chemo/XRT,
 currently receiving Velcade and dexamethasone), non-ischemic CM w/EF  ___%,
 atrial fibrillation s/p DCCV on Coumadin, SCC s/p XRT who presented on ___ for
 planned LV epicardial pacemaker lead placement with hospital course
 complicated by tachycardia, low-normal blood pressures, and ___.  // Eval for
 interval change  Eval for interval change
 
 IMPRESSION: 
 
 Severe cardiomegaly is unchanged.  Mediastinal widening is stable.  Mild
 vascular congestion is present.  There is no pneumothorax.  Left chest wall
 subcutaneous air is noted included in the field of view.
